icobrain ms
Helps physicians assess (sub)clinical parameters and, therefore, enables the early prediction of disability progression, relapses and treatment response in individual patients with MS.
Overview
The icobrain ms software helps physicians assess (sub)clinical parameters and, therefore, enables the early prediction of disability progression, relapses and treatment response in individual patients with MS.




Features
icobrain ms provides brain atrophy measures by:
• Tracking the annualized brain volume changes for whole brain and gray matter to evaluate disease progression.
• Comparing brain volumes and volume changes to an age-and gender matched normative healthy population.
Benefits
icobrain ms allows for the objective assessment of the lesion dissemination in space and time by:
• Detecting, quantifying and tracking the evolution of FLAIR white matter, T1 white matter hypointensities and contrast-enhancing T1 hyperintensities to evaluate disease activity.
• Reporting the distribution following the McDonald criteria (juxtacortical, periventricular, deep white matter and infratentorial).
Image examples
To find out more about this solution or any of the other 140+ applications on the Blackford Platform, please book a discovery call with our team.

Book a meeting
We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.
Book a Meeting